Evidence map›Paper›PMID 26292334›Full record

ReviewIEEE transactions on bio-medical engineering2015

A Review of Emerging Technologies for the Management of Diabetes Mellitus.

Konstantia Zarkogianni, Eleni Litsa, Konstantinos Mitsis, Po-Yen Wu, Chanchala D Kaddi, Chih-Wen Cheng, May D Wang, Konstantina S Nikita

Abstract readReview
In one paragraph

Review in IEEE transactions on bio-medical engineering, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Design and Development of Diabetes Management System Using Machine Learning.International journal of telemedicine and applications · 2020
    Article
  9. Improving Accuracy for Diabetes Mellitus Prediction by Using Deepnet.Online journal of public health informatics · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Konstantia Zarkogianni
Eleni Litsa
Konstantinos Mitsis
Po-Yen Wu
Chanchala D Kaddi
Chih-Wen Cheng
May D Wang
Konstantina S Nikita

Funding

Tissue and Animal UseU54CA119338 · NCI · EMORY UNIVERSITY · PI WANG, ZHONG · 2005 to 2009
$18.4M
Nanotechnology Linking Biomarkers with Cancer BehaviorR01CA108468 · NCI · EMORY UNIVERSITY · PI NIE, SHUMING · 2004 to 2008
$6.9M
Bioaffinity Nanoparticle Probes for Bioimaging (RMI)P20GM072069 · NIGMS · EMORY UNIVERSITY · PI NIE, SHUMING · 2004 to 2007
$2.6M
NCI NIH HHS R01 CA108468NCI NIH HHS U54 CA119338NIGMS NIH HHS P20 GM072069
6 · The paper itself

Abstract

objectiveHigh prevalence of diabetes mellitus (DM) along with the poor health outcomes and the escalated costs of treatment and care poses the need to focus on prevention, early detection and improved management of the disease. The aim of this paper is to present and discuss the latest accomplishments in sensors for glucose and lifestyle monitoring along with clinical decision support systems (CDSSs) facilitating self-disease management and supporting healthcare professionals in decision making.

methodsA critical literature review analysis is conducted focusing on advances in: 1) sensors for physiological and lifestyle monitoring, 2) models and molecular biomarkers for predicting the onset and assessing the progress of DM, and 3) modeling and control methods for regulating glucose levels.

resultsGlucose and lifestyle sensing technologies are continuously evolving with current research focusing on the development of noninvasive sensors for accurate glucose monitoring. A wide range of modeling, classification, clustering, and control approaches have been deployed for the development of the CDSS for diabetes management. Sophisticated multiscale, multilevel modeling frameworks taking into account information from behavioral down to molecular level are necessary to reveal correlations and patterns indicating the onset and evolution of DM.

conclusionIntegration of data originating from sensor-based systems and electronic health records combined with smart data analytics methods and powerful user centered approaches enable the shift toward preventive, predictive, personalized, and participatory diabetes care. SIGNIFICANCE: The potential of sensing and predictive modeling approaches toward improving diabetes management is highlighted and related challenges are identified.

Indexed as

Decision Support Systems, ClinicalDiabetes MellitusMonitoring, PhysiologicBiomarkersBlood GlucoseHumansBiomarkersBlood Glucose

Identifiers

PMID26292334
PMCPMC5859570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.